Study of Talabostat and Cisplatin in Advanced Melanoma
Public ClinicalTrials.gov record NCT00083252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the antitumor activity and safety of the combination of talabostat and cisplatin in patients with metastatic melanoma.
Study identification
- NCT ID
- NCT00083252
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 7, 2007
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Cancer Institute Medical Group, Inc. | Santa Monica | California | 90404 | — |
| University of Colorado Health Sciences Center | Aurora | Colorado | 80045 | — |
| Cancer Center of Florida | Ocoee | Florida | 34761 | — |
| Indiana Hematology Oncology Consultants | Indianapolis | Indiana | 46202 | — |
| New Mexico Cancer Center Alliance | Albuquerque | New Mexico | 87106 | — |
| NYU School of Medicine | New York | New York | 10016 | — |
| Fifth Avenue Medical Healthcare | New York | New York | 10128 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Cancer Center of the Carolinas | Greenville | South Carolina | 29615 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75246 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Cancer Care Northwest Research | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2007 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00083252 live on ClinicalTrials.gov.